In vitro and in vivo percutaneous absorption of catechol

被引:19
|
作者
Jung, CT [1 ]
Wickett, RR
Desai, PB
Bronaugh, RL
机构
[1] US FDA, Off Cosmet & Colors, Laurel, MD 20708 USA
[2] Univ Cincinnati, Div Pharmaceut Sci, Cincinnati, OH 45267 USA
关键词
catechol; percutaneous absorption; skin; penetration; hair dye; rat; human;
D O I
10.1016/S0278-6915(03)00040-1
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The Cosmetic Ingredient Review Expert Panel found insufficient data to conclude that catechol could be used safely in permanent hair dye products. Information was lacking on the extent of oxidation and skin absorption of remaining catechol. In vitro percutaneous absorption studies were conducted in human and rat skin using a consumer permanent hair dye spiked with 0.6% catechol. A 30-min application demonstrated 0.4% of the applied dose was absorbed through human skin and 0.2% through rat skin. The minimal absorption observed was due to the short exposure time and to partial oxidation of catechol by the dye developer. The fate of catechol remaining in rat skin after exposure in vitro and in vivo was investigated with additional absorption studies using catechol in ethanol. At 72 h, 24-h application of 4% catechol resulted in skin absorption of 81% of the applied dose in vitro and 53% in vivo. Skin levels measured at 24 h remained unchanged after 72 h. Therefore the skin reservoir did not contribute to the estimated systemic absorption. A deconvolution technique employed to predict skin absorption using plasma levels from intravenous and dermal administration overestimated in vivo skin absorption due to volatility of catechol in an ethanolic vehicle. Published by Elsevier Science Ltd.
引用
收藏
页码:885 / 895
页数:11
相关论文
共 50 条
  • [1] Percutaneous absorption of vanilloids: In vivo and in vitro studies
    Kasting, GB
    Francis, WR
    Bowman, LA
    Kinnett, GO
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1997, 86 (01) : 142 - 146
  • [2] Percutaneous absorption of salicylic acid - in vitro and in vivo studies
    Mateus, Rita
    Moore, David J.
    Hadgraft, Jonathan
    Lane, Majella E.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 475 (1-2) : 471 - 474
  • [3] Percutaneous Absorption in Man: In vitro-in vivo Correlation
    Lehman, P. A.
    Raney, S. G.
    Franz, T. J.
    SKIN PHARMACOLOGY AND PHYSIOLOGY, 2011, 24 (04) : 224 - 230
  • [4] Doramectin percutaneous absorption in dogs: in vivo and in vitro characterization
    Nejamkin, P.
    Albarellos, G. A.
    Sallovitz, J. M.
    Lanusse, C. E.
    JOURNAL OF VETERINARY PHARMACOLOGY AND THERAPEUTICS, 2012, 35 : 126 - 126
  • [5] In-vitro-in-vivo correlation in man for percutaneous absorption
    Franz, T. J.
    Lehman, P. A.
    Raney, S. G.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2010, 62 (06) : 802 - 802
  • [6] Comparative in vitro-in vivo percutaneous absorption of the pesticide propoxur
    van de Sandt, JJM
    Meuling, WJA
    Elliott, GR
    Cnubben, NHP
    Hakkert, BC
    TOXICOLOGICAL SCIENCES, 2000, 58 (01) : 15 - 22
  • [7] Can models of percutaneous absorption based on in vitro data in frogs predict in vivo absorption?
    Llewelyn, Victoria K.
    Berger, Lee
    Glass, Beverley D.
    PLOS ONE, 2020, 15 (07):
  • [8] Correction to: Predicting in vivo absorption of chloramphenicol in frogs using in vitro percutaneous absorption data
    Victoria K. Llewelyn
    Lee Berger
    Beverley D. Glass
    BMC Veterinary Research, 17
  • [9] Evaluation of in vivo animal and in vitro models for percutaneous absorption using human in vivo data
    Jakasa, Ivone
    TOXICOLOGY LETTERS, 2006, 164 : S324 - S324
  • [10] In vitro and in vivo percutaneous absorption of topical dosage forms:: case studies
    Csóka, I
    Csányi, E
    Zapantis, G
    Nagy, E
    Fehér-Kiss, A
    Horváth, G
    Blazsó, G
    Eros, I
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 291 (1-2) : 11 - 19